Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application for Zuranolone to the FDA in 2022
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
Essential Reads: A Comprehensive Review of Brexanolone for the Treatment of Postpartum Depression
This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.
For Women with Perinatal Mood and Anxiety Disorders, Can Nurses and Midwives Fill the Gaps in Mental Health Care?
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
Essential Reads: Maternal Suicide in the United States, The Latest Research & Data Collection Efforts
In a webinar put together by 2020 Mom, presenters provide an overview of maternal suicide, review risk factors for suicide in this population, and discuss efforts to generate accurate data on maternal suicide.
Essential Reads – Postpartum Psychosis: A Diagnosis for the DSMV
In a recent article, Margaret Spinelli, MD describes a proposal to the DSM-V committee of the American Psychiatric Association in 2020 arguing for the inclusion of postpartum psychosis as a unique diagnosis...
NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.Â
Toward a clearer risk model for postpartum psychosis
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on mitigating psychiatric relapse during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News on [...]
What Factors Promote Recovery in Postpartum Women with Opioid Use Disorder?
Parenting support, maternal bonding with the infant, engagement in an OUD treatment program, and recovery-specific support systems promoted recovery in postpartum women with opioid use disorders.
Essential Reads: Neurosteroids, Allopregnanolone and Vulnerability to Depression in Women
This article focuses on how GABA-ergic neurotransmitter systems may modulate the interaction between reproductive steroid and sex steroid systems, and sheds light on the role allopregnanolone may play in medicating vulnerability to depression.Â
Does Stress Increase Vulnerability to Postpartum Psychosis in High-Risk Women?
In studies of psychosis unrelated to childbirth, there is evidence linking stress to the onset of psychosis.Â